365 related articles for article (PubMed ID: 16141358)
1. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.
Hunyady L; Catt KJ
Mol Endocrinol; 2006 May; 20(5):953-70. PubMed ID: 16141358
[TBL] [Abstract][Full Text] [Related]
2. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.
Balakumar P; Jagadeesh G
Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in angiotensin II signaling.
Touyz RM; Berry C
Braz J Med Biol Res; 2002 Sep; 35(9):1001-15. PubMed ID: 12219172
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases.
El-Arif G; Khazaal S; Farhat A; Harb J; Annweiler C; Wu Y; Cao Z; Kovacic H; Abi Khattar Z; Fajloun Z; Sabatier JM
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408447
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling.
Lymperopoulos A; Borges JI; Carbone AM; Cora N; Sizova A
Pharmacol Res; 2021 Dec; 174():105943. PubMed ID: 34662735
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.
Mehta PK; Griendling KK
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C82-97. PubMed ID: 16870827
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes.
Kintscher U; Wakino S; Kim S; Fleck E; Hsueh WA; Law RE
Hypertension; 2001 Feb; 37(2 Pt 2):587-93. PubMed ID: 11230339
[TBL] [Abstract][Full Text] [Related]
8. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
[TBL] [Abstract][Full Text] [Related]
9. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.
Ushio-Fukai M; Zuo L; Ikeda S; Tojo T; Patrushev NA; Alexander RW
Circ Res; 2005 Oct; 97(8):829-36. PubMed ID: 16151024
[TBL] [Abstract][Full Text] [Related]
10. Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways.
Pang HW; Linares A; Couling L; Santollo J; Ancheta L; Daniels D; Speth RC
Endocrine; 2019 Nov; 66(2):349-359. PubMed ID: 31020463
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.
Dostal DE; Hunt RA; Kule CE; Bhat GJ; Karoor V; McWhinney CD; Baker KM
J Mol Cell Cardiol; 1997 Nov; 29(11):2893-902. PubMed ID: 9405164
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
13. Novel mechanisms of G-protein-coupled receptors functions: AT
Tóth AD; Turu G; Hunyady L; Balla A
Best Pract Res Clin Endocrinol Metab; 2018 Apr; 32(2):69-82. PubMed ID: 29678287
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms in H2O2-induced increase in AT1 receptor gene expression in cardiac fibroblasts: A role for endogenously generated Angiotensin II.
Anupama V; George M; Dhanesh SB; Chandran A; James J; Shivakumar K
J Mol Cell Cardiol; 2016 Aug; 97():295-305. PubMed ID: 27208880
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II signaling pathways mediated by tyrosine kinases.
Yin G; Yan C; Berk BC
Int J Biochem Cell Biol; 2003 Jun; 35(6):780-3. PubMed ID: 12676164
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II-triggered kinase signaling cascade in the central nervous system.
Bali A; Jaggi AS
Rev Neurosci; 2016 Apr; 27(3):301-15. PubMed ID: 26574890
[TBL] [Abstract][Full Text] [Related]
17. Vasopressor meets vasodepressor: The AT1-B2 receptor heterodimer.
Quitterer U; AbdAlla S
Biochem Pharmacol; 2014 Apr; 88(3):284-90. PubMed ID: 24462918
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
Zhao Y; Chen X; Cai L; Yang Y; Sui G; Fu S
J Cell Physiol; 2010 Oct; 225(1):168-73. PubMed ID: 20458733
[TBL] [Abstract][Full Text] [Related]
19. Hybrid formation between the intracellular faces of the bradykinin B2 and angiotensin II AT1 receptors and signal transduction.
Yu J; Prado GN; Taylor L; Pal-Ghosh R; Polgar P
Int Immunopharmacol; 2002 Dec; 2(13-14):1807-22. PubMed ID: 12489795
[TBL] [Abstract][Full Text] [Related]
20. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
Banday AA; Lokhandwala MF
Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
